NVP-TAE226
产品编号: DC7885
Featured
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
NVP-TAE 226 (TAE226) 是一种有效且具有 ATP 竞争性的双重 FAK 和 IGF-1R 抑制剂,IC50 分别为 5.5 nM、140 nM。NVP-TAE 226 (TAE226) 还有效抑制 Pyk2,胰岛素受体 (InsR),IC50 分为 3.5 nM、40 nM。
Cas No.: |
761437-28-9 |
名称: |
Benzamide, 2-[[5-chloro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]-N-methyl- |
别名: |
TAE226, TAE-226,TAE 226,NVPTAE226 |
SMILES: |
CNC(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCOCC4)OC |
分子式: |
C23H25ClN6O3 |
分子量: |
468.94 |
纯度: |
|
保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: |
|
In Vivo: |
|
In Vitro: |
|
References: |
NVP-TAE226 (< 1 μM) inhibits extracellular matrix-induced autophosphorylation of FAK (Tyr397) in serum-starved U87 cells. NVP-TAE226 (< 1 μM) also inhibits IGF-I-induced phosphorylation of IGF-1R and activity of its downstream target genes such as MAPK an |
Kinase Assay: |
|
Cell Assay: |
|
Animal Administration: |
|
References: |
|
MSDS
COA
LOT NO. |
DOWNLOAD |
|
|
2018-0101 |
|
询盘